Antibodies and other Reagents

Abcam ALS antibodies and Disease Markers

ALS Reproducible Antibody Platform (ALS RAP) – created as a public-private partnership by the ALS Association, the Motor Neurone Disease Association (UK), and the ALS Society of Canada to ensure the availability of the highest quality, validated antibodies developed using standard operating procedures that will be openly shared with the ALS research community. Notably, no form of intellectual property protection or patents will be filed for all new reproducible antibodies fully discovered and developed by ALS-RAP. This collaborative effort, based on open science and complete freedom to operate, will ensure the use of the highest-quality tools to increase the success of future drug discovery.

Proteintech Antibodies for ALS and FTD

Target ALS Antibody Core – Currently available:

• Poly(GP)monoclonal antibodies from two hybridoma clones. Both have been deposited at the Developmental Studies Hybridoma Bank (DHSB).
• Mouse Vacht polyclonal antibody. Investigators can request up to 10 aliquots (20 ul/aliquot).